Ekso Bionics Holdings Stock Buy Hold or Sell Recommendation
| EKSO Stock | USD 0.70 0.04 6.06% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Ekso Bionics Holdings is 'Strong Sell'. The recommendation algorithm takes into account all of Ekso Bionics' available fundamental, technical, and predictive indicators you will find on this site.
Check out Ekso Bionics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Ekso and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Ekso Bionics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Ekso |
Execute Ekso Bionics Buy or Sell Advice
The Ekso recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ekso Bionics Holdings. Macroaxis does not own or have any residual interests in Ekso Bionics Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ekso Bionics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Ekso Bionics Trading Alerts and Improvement Suggestions
| Ekso Bionics generated a negative expected return over the last 90 days | |
| Ekso Bionics has some characteristics of a very speculative penny stock | |
| Ekso Bionics has high historical volatility and very poor performance | |
| Ekso Bionics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 18.28 M. Net Loss for the year was (15.2 M) with profit before overhead, payroll, taxes, and interest of 6.75 M. | |
| Ekso Bionics Holdings currently holds about 31.91 M in cash with (12.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Ekso Bionics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from thelincolnianonline.com: Ekso Bionics Earns Hold Rating from Analysts at StockNews.com |
Ekso Bionics Returns Distribution Density
The distribution of Ekso Bionics' historical returns is an attempt to chart the uncertainty of Ekso Bionics' future price movements. The chart of the probability distribution of Ekso Bionics daily returns describes the distribution of returns around its average expected value. We use Ekso Bionics Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Ekso Bionics returns is essential to provide solid investment advice for Ekso Bionics.
| Mean Return | -0.61 | Value At Risk | -7.53 | Potential Upside | 6.06 | Standard Deviation | 3.86 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Ekso Bionics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Ekso Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Ekso Bionics, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading Ekso Bionics Holdings back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
| Shares | Xtx Topco Ltd | 2024-09-30 | 11.1 K | Tower Research Capital Llc | 2024-06-30 | 4.5 K | Advisor Group Holdings, Inc. | 2024-06-30 | 3.2 K | Ubs Group Ag | 2024-06-30 | 1.7 K | Harbour Investments, Inc. | 2024-09-30 | 458 | Tradewinds Capital Management, Llc | 2024-09-30 | 260 | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 258 | Goss Wealth Management Llc | 2024-06-30 | 200 | Bank Of America Corp | 2024-06-30 | 155 | Armistice Capital, Llc | 2024-09-30 | 2.2 M | Kent Lake Capital Llc | 2024-06-30 | 696 K |
Ekso Bionics Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 3.2M | 2.0M | 27.5M | (19.9M) | (11.9M) | (11.3M) | |
| Free Cash Flow | (15.8M) | (8.8M) | (11.2M) | (14.9M) | (12.2M) | (12.8M) | |
| Capital Expenditures | 131K | 60K | 59K | 194K | 157K | 149.2K | |
| Net Income | (12.1M) | (15.8M) | (9.8M) | (15.1M) | (15.2M) | (16.0M) | |
| End Period Cash Flow | 10.9M | 12.9M | 40.4M | 20.5M | 8.6M | 8.2M | |
| Other Non Cash Items | 1.2M | 319K | 134K | (647K) | (207K) | (196.7K) | |
| Change To Inventory | 893K | 379K | (752K) | (1.4M) | 232K | 243.6K | |
| Net Borrowings | (54K) | (2.2M) | (2.4M) | 288K | 259.2K | 272.2K | |
| Depreciation | 690K | 620K | 561K | 887K | 1.7M | 898.9K | |
| Change To Netincome | (3.5M) | 2.1M | (1.5M) | 2.1M | 1.9M | 1.6M | |
| Investments | (60K) | 0.0 | (59K) | (5.2M) | (5.1M) | (4.9M) |
Ekso Bionics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Ekso Bionics or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Ekso Bionics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Ekso stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.81 | |
β | Beta against Dow Jones | 1.55 | |
σ | Overall volatility | 3.76 | |
Ir | Information ratio | -0.19 |
Ekso Bionics Volatility Alert
Ekso Bionics Holdings exhibits very low volatility with skewness of -0.82 and kurtosis of 2.85. Ekso Bionics Holdings is a potential penny stock. Although Ekso Bionics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Ekso Bionics Holdings. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Ekso instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Ekso Bionics Fundamentals Vs Peers
Comparing Ekso Bionics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Ekso Bionics' direct or indirect competition across all of the common fundamentals between Ekso Bionics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Ekso Bionics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Ekso Bionics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Ekso Bionics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Ekso Bionics to competition |
| Fundamentals | Ekso Bionics | Peer Average |
| Return On Equity | -0.74 | -0.31 |
| Return On Asset | -0.24 | -0.14 |
| Profit Margin | (0.63) % | (1.27) % |
| Operating Margin | (0.64) % | (5.51) % |
| Current Valuation | 13.34 M | 16.62 B |
| Shares Outstanding | 22 M | 571.82 M |
| Shares Owned By Insiders | 7.91 % | 10.09 % |
| Shares Owned By Institutions | 25.25 % | 39.21 % |
| Number Of Shares Shorted | 86.76 K | 4.71 M |
| Price To Earning | (0.67) X | 28.72 X |
| Price To Book | 1.03 X | 9.51 X |
| Price To Sales | 0.86 X | 11.42 X |
| Revenue | 18.28 M | 9.43 B |
| Gross Profit | 6.75 M | 27.38 B |
| EBITDA | (13.2 M) | 3.9 B |
| Net Income | (15.2 M) | 570.98 M |
| Cash And Equivalents | 31.91 M | 2.7 B |
| Cash Per Share | 2.45 X | 5.01 X |
| Total Debt | 7.17 M | 5.32 B |
| Debt To Equity | 0.07 % | 48.70 % |
| Current Ratio | 8.16 X | 2.16 X |
| Book Value Per Share | 0.68 X | 1.93 K |
| Cash Flow From Operations | (12.05 M) | 971.22 M |
| Short Ratio | 0.91 X | 4.00 X |
| Earnings Per Share | (0.64) X | 3.12 X |
| Target Price | 5.5 | |
| Number Of Employees | 70 | 18.84 K |
| Beta | 1.48 | -0.15 |
| Market Capitalization | 15.29 M | 19.03 B |
| Total Asset | 28.92 M | 29.47 B |
| Retained Earnings | (239.15 M) | 9.33 B |
| Working Capital | 12.09 M | 1.48 B |
| Current Asset | 17.57 M | 9.34 B |
Note: Acquisition by Steven Sherman of 242679 shares of Ekso Bionics subject to Rule 16b-3 [view details]
Ekso Bionics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Ekso . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Ekso Bionics Buy or Sell Advice
When is the right time to buy or sell Ekso Bionics Holdings? Buying financial instruments such as Ekso Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Ekso Bionics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Outsourcing Thematic Idea Now
Outsourcing
Companies involved in providing outsourcing and staffing services to business across different domains. The Outsourcing theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Outsourcing Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Ekso Bionics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.64) | Revenue Per Share 1.004 | Quarterly Revenue Growth (0.10) | Return On Assets (0.24) | Return On Equity (0.74) |
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.